Page last updated: 2024-10-20

pyrazinamide and Empyema, Pleural, Tuberculous

pyrazinamide has been researched along with Empyema, Pleural, Tuberculous in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
" On the basis of limited experience, the combination of tube thoracostomy or catheter drainage and high-end dosing of anti-TB drugs has been recommended as an initial approach to these lesions."1.42Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature. ( Barrie, J; Long, R; Peloquin, CA, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Long, R1
Barrie, J1
Peloquin, CA1
COSTA, G1
MORETTI, E1

Other Studies

2 other studies available for pyrazinamide and Empyema, Pleural, Tuberculous

ArticleYear
Therapeutic drug monitoring and the conservative management of chronic tuberculous empyema: case report and review of the literature.
    BMC infectious diseases, 2015, Aug-12, Volume: 15

    Topics: Aged, 80 and over; Antitubercular Agents; Bronchial Fistula; Canada; Croatia; Diagnosis, Differentia

2015
[Pyrazinamide in solution, for topical use, in the treatment of tuberculous empyema].
    Minerva medica, 1958, Aug-29, Volume: 49, Issue:69

    Topics: Empyema, Tuberculous; Humans; Niacin; Nicotinic Acids; Pyrazinamide; Tuberculosis; Tuberculosis, Pul

1958